3'-Substituted 7-halogenoindirubins, a new class of cell death inducing agents.
about
Indirubin and Indirubin Derivatives for Counteracting Proliferative DiseasesCancer and virus leads by HTS, chemical design and SEA data miningAn inhibitor-driven study for enhancing the selectivity of indirubin derivatives towards leishmanial Glycogen Synthase Kinase-3 over leishmanial cdc2-related protein kinase 36-Bromoindirubin-3'-oxime inhibits JAK/STAT3 signaling and induces apoptosis of human melanoma cells.From Drug Screening to Target Deconvolution: a Target-Based Drug Discovery Pipeline Using Leishmania Casein Kinase 1 Isoform 2 To Identify Compounds with Antileishmanial Activity.A novel 7-bromoindirubin with potent anticancer activity suppresses survival of human melanoma cells associated with inhibition of STAT3 and Akt signalingIsatin derivatives with activity against apoptosis-resistant cancer cells.Soluble 3',6-substituted indirubins with enhanced selectivity toward glycogen synthase kinase -3 alter circadian period.MLS-2384, a new 6-bromoindirubin derivative with dual JAK/Src kinase inhibitory activity, suppresses growth of diverse cancer cellsInhibition mechanism of CDK-2 and GSK-3β by a sulfamoylphenyl derivative of indoline-a molecular dynamics study.The Role of Indirubins in Inflammation and Associated Tumorigenesis.Water-soluble cationic derivatives of indirubin, the active anticancer component from Indigo naturalis.Studies on the acetylation and NMR reassignment of indirubin derivatives.Induction of atypical cell death in thyroid carcinoma cells by the indirubin derivative 7-bromoindirubin-3'-oxime (7BIO).Effects of indirubin and isatin on cell viability, mutagenicity, genotoxicity and BAX/ERCC1 gene expression.
P2860
Q26784341-AF6596D5-C13B-468C-A6C5-8D912038EE1AQ33508912-2554AEF9-3938-4B2F-B544-33063FAFC898Q33688195-2EB935BF-1D7F-4E55-876A-CEA4F401F7BCQ35022350-5A0325C2-3B40-4764-8E54-E4F852623A53Q35931675-9F021066-85DE-4CCC-B573-EAD6003B91A0Q36384334-AB77866E-85DC-43C9-BEA9-2813F9DD943BQ36642961-45853015-2A1A-4D62-A8D3-47F0A7B27D08Q37280604-91D2635E-543D-4DFA-9156-ED95ECB0F327Q37591464-44241E2D-E7BA-4230-A0DB-A1A8B588FF96Q38670935-A38F74C4-FC66-4C8D-BB57-9BA3B580E424Q38988591-513B7687-275E-4582-B4F6-E6974516B852Q39256558-7925B6C1-698A-4D0B-80E6-04BBFCC85C56Q43193520-630A5047-032B-4CD7-A97D-45C8375731AFQ43224690-E15B97B2-AEB7-4F3C-8D70-9B00DE06E9ADQ50163458-8B01DE2E-6373-4AC2-AA98-96D27A18F55E
P2860
3'-Substituted 7-halogenoindirubins, a new class of cell death inducing agents.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
3'-Substituted 7-halogenoindirubins, a new class of cell death inducing agents.
@en
type
label
3'-Substituted 7-halogenoindirubins, a new class of cell death inducing agents.
@en
prefLabel
3'-Substituted 7-halogenoindirubins, a new class of cell death inducing agents.
@en
P2093
P356
P1476
3'-Substituted 7-halogenoindirubins, a new class of cell death inducing agents
@en
P2093
Alexios-Leandros Skaltsounis
Karima Bettayeb
Laurent Meijer
Marina Kritsanida
Olivier Lozach
Panagiotis Polychronopoulos
Yoan Ferandin
P304
P356
10.1021/JM060314I
P407
P577
2006-07-01T00:00:00Z